Hepatitis
Conference Coverage
HPV-Mediated Head, Neck Cancers Predicted to Rise for Decades
Radiotherapy-cisplatin combo is boosting survival in certain patients, head and neck surgeon tells AVAHO Virtual Meeting...
News
Hepatitis screening now for all patients with cancer on therapy
All patients with cancer who are candidates for systemic therapy should be screened for hepatitis B, says the American Society of Clinical...
News
New CDC guidance for health care personnel exposed to HCV
Baseline testing of the source patient and the HCP should be performed as soon as possible, preferably within 48 hours of exposure.
Conference Coverage
Hep C sofosbuvir/daclatasvir combo promising for COVID-19
“We need to remember that conducting research amidst a pandemic with overwhelmed hospitals is a clear challenge, and we cannot be sure of success...
Original Research
Retreatment of Hepatitis C Infection With Direct-Acting Antivirals
Treating veterans with direct-acting antivirals who failed an initial treatment for HCV infection has a high success rate, although patients with...
Original Research
Outcomes Comparison of the Veterans’ Choice Program With the Veterans Affairs Health Care System for Hepatitis C Treatment
The rates of cure for patients with hepatitis C virus at 12 weeks were similar between the Veterans Health Administration and the VA Choice...
News
HCV screening risk factors in pregnant women need updating
Large study of pregnant women highlights the potential value of universal screening for hepatitis C virus.
Original Research
Blistering Disease During the Treatment of Chronic Hepatitis C With Ledipasvir/Sofosbuvir
Hepatitis C virus-associated porphyria cutanea tarda can result from viral-induced inhibition of uroporphyrinogen...
Original Research
Outcomes Comparison of the Veterans’ Choice Program With the Veterans Affairs Healthcare System for Hepatitis C Treatment
The rates of cure at 12 weeks were similar between VA and Choice program providers and were comparable to the national average at the time, even...
Original Research
A Case-Based Review of Iron Overload With an Emphasis on Porphyria Cutanea Tarda, Hepatitis C, C282Y Heterozygosity, and Coronary Artery Disease
Iron overload can impact disease progression and treatment options for patients with comorbid conditions, such as porphyria cutanea tarda,...